20 Participants Needed

Behavioral Therapy for Cornelia de Lange Syndrome

PF
MD
Overseen ByMichelle D Chin, MS, MPH
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on helping children with Cornelia de Lange syndrome (CdLS) who exhibit problem behaviors, such as aggression or self-injury. Researchers aim to identify the triggers of these behaviors and develop a treatment model to reduce them. The trial uses a special behavioral therapy called ABA-based functional analysis and treatment (Applied Behavior Analysis) to assess and address these issues. Children aged 3 to 15 with CdLS and frequent problem behaviors may qualify if their parents can attend clinic visits and implement a behavior plan at home. Families of children with CdLS who do not exhibit problem behaviors can also participate by providing regular updates for two years. As an unphased trial, this study offers families the chance to contribute to groundbreaking research that could improve the lives of children with CdLS.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that this behavioral therapy is safe for children with Cornelia de Lange Syndrome?

Research has shown that Applied Behavior Analysis (ABA) treatments are generally safe and well-tolerated. Studies have found that ABA effectively reduces problem behaviors in children. A review of research found that trial-based functional analyses, a component of ABA, can safely help manage challenging behaviors. Additionally, a retrospective study showed that when parents led ABA interventions, children experienced positive results without major safety issues. Overall, ABA treatments have a strong safety record, particularly in reducing problem behaviors in children.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how ABA-based functional analysis and treatment can help manage problem behaviors in children with Cornelia de Lange Syndrome (CdLS). Unlike typical interventions that might rely on medication or generalized behavioral strategies, this approach is personalized, focusing on understanding the specific triggers and functions of each child's behavior. This tailored technique could lead to more effective and sustainable behavioral improvements, offering new hope for families dealing with the challenges of CdLS.

What evidence suggests that this behavioral therapy is effective for problem behavior in Cornelia de Lange Syndrome?

Research has shown that ABA-based functional analysis, a treatment available in this trial, can reduce problem behaviors in children with Cornelia de Lange Syndrome (CdLS). Early results suggest these treatments can lower problem behaviors by 80% or more from the starting point. Studies have found that children with similar issues, such as those with Autism Spectrum Disorder (ASD), also benefit significantly from this method. The treatment identifies the reasons behind problem behaviors and develops specific strategies to address them. This approach successfully improves behavior by promoting positive actions and reducing negative ones.12678

Who Is on the Research Team?

PF

Patricia F Kurtz, PhD

Principal Investigator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Are You a Good Fit for This Trial?

This trial is for English-speaking parents of children aged 3-15 with Cornelia de Lange syndrome (CdLS). It includes those whose children exhibit self-injurious behavior, aggression, or disruptive behavior and can attend clinic visits. Children without these behaviors are in the control group.

Inclusion Criteria

I am an English-speaking parent of a child with CdLS and willing to complete study measures.
I am an English-speaking parent of a child with CdLS, willing to attend clinic visits, complete study tasks, and follow a behavior plan.

Exclusion Criteria

Children with CdLS in the treatment group should not show certain behaviors, be younger than 3 or older than 15, or require extensive medical care that could affect participation. Also, parents of these children should be willing to complete study procedures and be able to speak English.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-Visit Assessments

Parents complete research measures at home and participate in phone interviews to assess child behavior and preferences.

2-4 weeks
Remote assessments and phone interviews

Treatment

Participants attend clinic services for assessment and treatment of problem behaviors, including functional analysis and parent training.

2 days
2 full days and one half-day at Kennedy Krieger Institute

Follow-up

Participants are monitored for safety and effectiveness after treatment, with follow-up visits and phone calls.

12 weeks
Follow-up phone calls at 1, 4, 8, and 12 weeks post-treatment

Long-term Monitoring (Control Group)

Control group participants are monitored every 3 months for up to 2 years to track the emergence of problem behavior.

2 years
Quarterly monitoring

What Are the Treatments Tested in This Trial?

Interventions

  • ABA-based functional analysis and treatment
Trial Overview The study tests a behavioral assessment and treatment based on Applied Behavior Analysis (ABA) for managing problem behaviors in kids with CdLS. The goal is to reduce such behaviors by at least 80% using function-based treatments.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: ABA-based functional analysis and treatmentExperimental Treatment1 Intervention
Group II: No Problem behavior Control GroupActive Control1 Intervention

ABA-based functional analysis and treatment is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as ABA Therapy for:
🇪🇺
Approved in European Union as ABA Therapy for:
🇨🇦
Approved in Canada as ABA Therapy for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Lead Sponsor

Trials
93
Recruited
25,200+

Published Research Related to This Trial

Functional Analytic Psychotherapy (FAP) utilizes behavior-analytic principles to improve interpersonal skills in adult outpatients, focusing on how therapists can provide social reinforcement to encourage positive behavioral changes.
Emerging empirical support for FAP highlights the need for further research on training therapists, conducting functional analyses, and ensuring effective treatment without creating aversive environments, presenting both challenges and opportunities for clinical behavior analysts.
The challenge of understanding process in clinical behavior analysis: the case of functional analytic psychotherapy.Follette, WC., Bonow, JT.[2021]
In a case study of a 7-year-old girl with severe mental retardation and Cornelia-de-Lange syndrome, breath-holding was identified as a behavior primarily used to gain attention.
An intervention combining extinction, scheduled attention, and a picture card communication system effectively reduced the frequency of breath-holding episodes, demonstrating a successful behavioral modification strategy.
Functional analysis and intervention for breath holding.Kern, L., Mauk, JE., Marder, TJ., et al.[2018]
In a study of 49 individuals with Cornelia de Lange syndrome, a significant number exhibited behavioral challenges, including sleep disturbances (55%), daily aggression (49%), and self-injury (44%), highlighting the need for tailored support.
The presence of these behavioral issues correlated with the severity of mental retardation and the occurrence of autistic-like symptoms, indicating that the degree of cognitive impairment may influence the behavioral phenotype and support requirements throughout life.
Behavioural phenotype of Cornelia de Lange syndrome.Berney, TP., Ireland, M., Burn, J.[2022]

Citations

Behavioral Assessment and Treatment of Problem ...The goals of this clinical trial are to identify factors associated with the development of problem behavior in Cornelia de Lange syndrome (CdLS) and to ...
Behavioral Assessment and Treatment of Problem Behavior in ...The goals of this clinical trial are to identify factors associated with the development of problem behavior in Cornelia de Lange syndrome (CdLS) and to ...
Cornelia de Lange Syndrome - GeneReviews - NCBI - NIHCornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features.
San Mateo Clinical Trial Behavioral Assessment and Treatment ...Preliminary findings from functional analyses and other assessments in CdLS indicate differences in forms of problem behavior, functions for problem behavior, ...
A comparative effectiveness trial of functional behavioral ...This comparative effectiveness study, conducted with 57 young children with autism spectrum disorder, evaluated the results of FBAs that did (n = 26) and did ...
INTERVENTIONS FOR SELF-INJURIOUS BEHAVIOURA young girl (LH) with Cornelia de Lange syndrome was described who, at age 14, had been displaying severe self-injury for ten years. Medication ...
A Systematic Review of Trial-Based Functional Analysis ...The purpose of this paper is to systematically review peer-reviewed studies which implemented trial-based functional analyses of challenging ...
Parent-Led Applied Behavior Analysis to Impact Clinical ...Objective: This study reports findings from a retrospective chart review of clinical outcomes for children that received parent-led ABA ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security